BerGenBio ASA
BRRGF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $1 | $0 |
| % Growth | 0% | 246.8% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $2 | $1 | $0 |
| % Margin | 100% | 100% | 100% | – |
| R&D Expenses | $1 | $1 | $22 | $11 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5 | $5 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $24 | $24 | $12 | $16 |
| Operating Expenses | $30 | $30 | $34 | $27 |
| Operating Income | -$27 | -$27 | -$34 | -$27 |
| % Margin | -1,155.6% | -1,155.6% | -4,922.9% | – |
| Other Income/Exp. Net | $0 | $0 | $5 | $2 |
| Pre-Tax Income | -$27 | -$27 | -$29 | -$25 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$27 | -$27 | -$29 | -$25 |
| % Margin | -1,146% | -1,146% | -4,204% | – |
| EPS | -0.69 | -0.69 | -2.39 | -2.08 |
| % Growth | 0% | 71.1% | -14.9% | – |
| EPS Diluted | -0.69 | -0.69 | -2.39 | -2.08 |
| Weighted Avg Shares Out | 39 | 39 | 12 | 12 |
| Weighted Avg Shares Out Dil | 39 | 39 | 12 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $6 | $4 |
| Interest Expense | $0 | $0 | $1 | $2 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$27 | -$27 | -$28 | -$23 |
| % Margin | -1,150.9% | -1,150.9% | -4,058.1% | – |